Bureau Veritas


Continued strong organic growth; 2025 targets confirmed and HSD growth looks achievable

25/07/25 -"BV’s H1 results met consensus and our expectations on sales but slightly exceeded them on profits. Organic growth was above 6% in Q2, with strong growth in M&O and Industry. Certification ..."

Pages
60
Language
English
Published on
25/07/25
You may also be interested by these reports :
31/07/25
Even though H1 operating results missed street expectations, there was a massive FCF beat. Moreover, there were important – though early stage – ...

30/07/25
Securitas beat expectations in Q2 2025, with solid organic growth, supported by North America and Europe, and a broad-based improvement in operating ...

25/07/25
BV’s H1 results met consensus and our expectations on sales but slightly exceeded them on profits. Organic growth was above 6% in Q2, with strong ...

25/07/25
SGS’s H1 results were broadly in line with Refinitiv consensus estimates but slightly below our expectations. Organic growth was steady and the ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO